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Organophosphate (OP) pesticides are potent 
toxicants that target the nervous systems of 
insects and other pests (Jokanovic 2009). OPs 
operate primarily through the inhibition of 
acetylcholinesterase, an enzyme that degrades 
the neurotransmitter acetylcholine, resulting 
in a buildup of acetylcholine in the neuronal 
junction (Jeyaratnam and Maroni 1994). 
However, cholinergic inhibition may not be 
the sole mechanism of effect, particularly in 
cases of low-level exposure (Costa 2006; Ray 
and Richards 2001; Timofeeva et al. 2008). 
Although accounts of human poisoning with 
these compounds have reported symptoms 
such as impaired concentration, slowed infor-
mation processing and motor function, anxi-
ety, confusion, tremors, seizure, and death 
(Jeyaratnam and Maroni 1994; Levin and 
Rodnitzky 1976), few studies have investi-
gated the health effects in humans of low-
level chronic exposure to OP pesticides. The 
potential effects of such low-level exposures 
on neurobehavioral functioning are particu-
larly relevant for fetuses and young children, 
who may be especially vulnerable to neuro-
toxicants because of their immature nervous 
systems, their rapid rate of brain growth and 
development in utero and during early child-
hood, and their low levels of the enzymes 
involved in the metabolism and detoxifica-
tion of OP pesticides (Eskenazi et al. 1999; 
Huen et al. 2009). Animal studies have found 
adverse effects of OP exposure during the pre-
natal and early postnatal periods (Costa 2006; 
Eskenazi et al. 1999).
Although research is limited, a few recent 
epidemiologic studies have reported asso-
ciations between in utero OP exposure and 
adverse effects on neurobehavioral devel-
opment (Engel et al. 2007; Eskenazi et al. 
2007; Rauh et al. 2006; Young et al. 2005). 
These studies have found that biomarkers 
of prenatal OP exposure are associated with 
an increased number of abnormal neonatal 
reflexes, as measured by the Brazelton Scales 
of Neonatal Development (Engel et al. 2007; 
Young et al. 2005), and poorer mental devel-
opment in early childhood, as measured on 
the Bayley Scales of Infant Development 
(Eskenazi et al. 2007; Rauh et al. 2006). 
Rauh et al. (2006) also found in a cohort of 
3-year-olds living in New York City that con-
centrations of the OP pesticide chlorpyrifos 
in maternal serum were associated with the 
mothers’ report of symptoms consistent with 
pervasive developmental disorder (PDD) as 
well as of attention deficit/hyperactivity disor-
der (ADHD) or attention problems. A recent 
cross-sectional study also reported associations 
between child OP metabolite concentrations 
and ADHD in 8- to 15-year-olds representa-
tive of the U.S. population (Bouchard et al. 
2010). Although we previously reported that 
prenatal OP metabolite concentrations were 
associated with mothers’ report of PDD 
symptoms in 2-year-olds living in the agri-
cultural Salinas Valley of California, we did 
not find an association between maternal or 
child dialkyl phosphates (DAPs) and meas-
ures of attention at 2 years of age (Eskenazi 
et al. 2007). However, the children in our 
study were younger—potentially too young 
at 2 years of age to manifest attention prob-
lems or for mothers to detect them. Although 
ADHD, characterized by inattention, impul-
sivity, and/or hyperactivity, is occasionally 
diagnosed in children as young as 2 or 3 years, 
it is more apparent after children begin school 
and is more commonly reported in boys than 
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Background: Exposure to organophosphate (OP) pesticides, well‑known neurotoxicants, has been 
associated with neurobehavioral deficits in children. 
oBjectives: We investigated whether OP exposure, as measured by urinary dialkyl phosphate 
(DAP) metabolites in pregnant women and their children, was associated with attention‑related 
outcomes among Mexican‑American children living in an agricultural region of California.
Methods: Children were assessed at ages 3.5 years (n = 331) and 5 years (n = 323). Mothers com‑
pleted the Child Behavior Checklist (CBCL). We administered the NEPSY‑II visual attention sub‑
test to children at 3.5 years and Conners’ Kiddie Continuous Performance Test (K‑CPT) at 5 years. 
The K‑CPT yielded a standardized attention deficit/hyperactivity disorder (ADHD) Confidence 
Index score. Psychometricians scored behavior of the 5‑year‑olds during testing using the Hillside 
Behavior Rating Scale.
results: Prenatal DAPs (nanomoles per liter) were nonsignificantly associated with maternal 
report of attention problems and ADHD at age 3.5 years but were significantly related at age 5 years 
[CBCL attention problems: β = 0.7 points; 95% confidence interval (CI), 0.2–1.2; ADHD: β = 1.3; 
95% CI, 0.4–2.1]. Prenatal DAPs were associated with scores on the K‑CPT ADHD Confidence 
Index > 70th percentile [odds ratio (OR) = 5.1; 95% CI, 1.7–15.7] and with a composite ADHD 
indicator of the various measures (OR = 3.5; 95% CI, 1.1–10.7). Some outcomes exhibited evidence 
of effect modification by sex, with associations found only among boys. There was also limited evi‑
dence of associations between child DAPs and attention.
conclusions: In utero DAPs and, to a lesser extent, postnatal DAPs were associated adversely with 
attention as assessed by maternal report, psychometrician observation, and direct assessment. These 
associations were somewhat stronger at 5 years than at 3.5 years and were stronger in boys.
key words: ADHD, attention, Child Behavior Checklist, DAPs, farmworker, Mexican 
Americans, neurobehavior, organophosphates, pesticides. Environ Health Perspect 118:1768–1774 
(2010). doi:10.1289/ehp.1002056 [Online 19 August 2010]
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in girls (Pastor and Reuben 2008; Staller and 
Faraone 2006).
The aim of this paper is to investigate 
associations between in utero and childhood 
OP pesticide exposure as assessed by uri-
nary DAP metabolites and attention-related 
outcomes in 3.5- and 5-year-old Mexican-
American children living in an agricultural 
community in California. We include assess-
ment of attentional problems based not only 
on maternal report, as in previous studies, but 
also by direct neuropsychological testing and 
psychometrician observation.
Materials and Methods
Participants and recruitment. The Center 
for the Health Assessment of Mothers and 
Children of Salinas (CHAMACOS) is a 
prospective birth cohort aimed at studying 
the association of pesticides and other envi-
ronmental agents on the health of pregnant 
women and their children living in the Salinas 
Valley, California. Details for this study have 
been described previously (Eskenazi et al. 
2004, 2007). Briefly, women in their first half 
of pregnancy were recruited between October 
1999 and October 2000 from participating 
prenatal care clinics serving the farmworker 
community. Eligible women were ≥ 18 years 
of age, eligible for California’s low-income 
health insurance program, planning to deliver 
at the county medical center, and spoke 
Spanish or English. Women gave written 
informed consent to participate. The study 
was approved by the institutional review 
board at University of California, Berkeley.
We followed 526 women to delivery of 
a liveborn, surviving singleton. We excluded 
from the present analyses children who did 
not have a prenatal DAP metabolite measure-
ment (n = 2), who had a medical condition 
that could affect neurobehavioral assessment 
(n = 3; deafness, Down syndrome, hydro-
cephalus), or who were lost to follow-up or 
did not participate at the 3.5- or 5-year study 
visit (n = 173). The final population included 
348 children who had available data at 3.5 
and/or 5 years of age. Total DAPs were meas-
ured in maternal urine collected at two time 
points during pregnancy and in child urine 
collected at the 3.5-year and 5-year visits. 
Levels of DAPs were similar in mothers of 
children included in the present analysis rela-
tive to those whose children were not (t-test 
p = 0.40). Distributions of other covariates 
measured before 3.5 years of age were also 
similar, except that more boys than girls had 
dropped from the study (χ2 p = 0.04).
Maternal interviews and assessments. We 
interviewed mothers twice during pregnancy 
(mean gestation, 14.0 and 26.6 weeks), after 
delivery, and when children were 6 months 
and 1, 2, 3.5, and 5 years of age. Interviews 
were conducted by bilingual, bicultural 
interviewers in Spanish or English. Mothers 
were administered the Peabody Picture 
Vocabulary Test (PPVT) (Dunn and Dunn 
1981; Dunn et al. 1986) at the 6-month visit 
to assess receptive vocabulary, which was used 
as an indicator of verbal intelligence, and the 
Center for Epidemiologic Studies Depression 
Scale (CES-D) (Radloff 1977) at the 3.5-year 
visit. A registered nurse abstracted prenatal 
and delivery medical records.
Attention-related outcomes. We measured 
attention-related outcomes in three ways: 
maternal report of child behavior at 3.5 and 5 
years of age; direct assessment of the child at 
3.5 and 5 years; and psychometrician’s report 
of the behavior of the child during testing at 
5 years.
Mothers completed the Child Behavior 
Checklist (CBCL) for 1.5–5 years of age 
(Achenbach and Rescorla 2000) as part of the 
maternal interview at the 3.5- and 5-year visits 
to assess emotional/behavioral problems and 
competencies of the children. This 99-item 
scale, which is available in English and Spanish 
and has been widely used in cross-cultural 
research, collects data on a variety of behaviors 
that the parent rates as “not true,” “somewhat 
true,” or “very true/often true” currently or 
within the preceding 2 months. Questions are 
combined to create scores reflecting possible 
problem areas, including some correspond-
ing to Diagnostic and Statistical Manual of 
Mental Disorders, 4th ed. (DSM-IV) diagnoses 
(American Psychiatric Association 2000) and 
others reflecting problem syndrome areas. The 
present analyses focused on two related atten-
tion scores: the attention problems scale and 
the DSM-related ADHD scale. Scores can be 
examined continuously or by the proportion 
above a standard cutoff score, for example, 
> 93rd percentile (borderline clinical range) or 
> 97th percentile (clinical range). Because few 
children fell into the clinical-range category for 
these scales (n = 3–11), we used the borderline 
clinical range cut-point as well as continuous 
raw scores in multivariate analyses.
Children also completed a battery of 
neuro developmental tests at each visit. At 
the 3.5-year visit, the visual attention sub-
test of the NEPSY-II (Korkman et al. 1997) 
was administered to children by trained psy-
chometricians. Children were asked to cir-
cle specific images on a page of pictures that 
included distracters. For data analysis, we 
used continuous scores scaled to a normative 
sample of U.S. children; the age-standardized 
mean ± SD for this subtest is 10 ± 3.
During the 5-year neurodevelopmen-
tal assessment, which took approximately 
2 hr to complete, trained psychometricians 
administered to children the Conners’ Kiddie 
Continuous Performance Test (K-CPT) 
(Conners and Staff 2001). The K-CPT is a 
7-min computerized test that assesses reaction 
time, accuracy, and impulse control. Briefly, 
children were instructed to press the space bar 
when they saw any image on the computer 
screen except a ball. The computer program 
yields T-scores age-standardized to a general 
U.S. population (mean ± SD = 50 ± 10) for 
errors of commission (i.e., the child responds 
when he or she should not), errors of omis-
sion (i.e., the child fails to respond when he 
or she should), and hit reaction time. We 
examined T-scores continuously and cat-
egorically using the cutoff of T-score > 65, 
which is considered markedly atypical. The 
program also combines measures to gener-
ate a clinical ADHD Confidence Index score 
(range, 0–100). For statistical analyses, we 
use continuous Confidence Index percentiles 
and selected a cut-point of > 70th percentile 
(meaning that 70% of children performing 
similarly on the test could be correctly classi-
fied as having clinical ADHD).
Following the 5-year neurodevelopmen-
tal assessment, psychometricians blinded to 
exposure status answered several subjective 
questions evaluating the behavior of the child 
during the 2-hr visit, including four questions 
derived from the seven-item Hillside Behavior 
Rating Scale (Gittelman and Klein 1985). We 
summed responses to two questions assessing 
motor activity and distractibility to create an 
adapted ADHD symptoms scale. The Hillside 
Scale is associated with parent and teacher rat-
ings and has been found to add significantly 
to the clinical prediction of ADHD (Willcutt 
et al. 1999). We created a dichotomized 
Hillside outcome variable with scores ≥ 7 of 
12 possible points (representing < 10% of 
children) to flag children displaying a higher 
degree of attention problems based on psy-
chometricians’ observation.
To identify children whose behaviors on 
multiple indices at 5 years of age were most 
suggestive of possible ADHD within our 
cohort, we created a composite ADHD vari-
able that combined maternal report (CBCL), 
child testing (K-CPT), and psychometrician 
report (Hillside). Children were coded 1 for 
the ADHD indicator if they met at least two 
of the following conditions at 5 years of age: 
CBCL ADHD scale in borderline clinical 
range (maternal report); standardized K-CPT 
ADHD Confidence Index ≥ 60% (child test-
ing); and Hillside ADHD scale in the upper 
quartile of values (psychometrician report).
The CBCL was completed by 331 mothers 
at the 3.5-year interview and 323 mothers at 
the 5-year interview. NEPSY scores were avail-
able for 320 3.5-year-olds, and K-CPT scores 
were available for 312 5-year-olds. Hillside 
scores were available for 322 5-year-olds.
Pesticide exposure measurement. Details of 
urine collection, analysis, and quality control 
procedures, including detection limits and use 
of blanks and spikes, are described elsewhere 
Marks et al.
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(Bradman et al. 2005). Urine specimens were 
typically collected at the time of interview/
neurodevelopmental assessment and were ali-
quoted and stored at –80°C until shipment on 
dry ice to the Centers for Disease Control and 
Prevention (CDC) for analysis. DAPs were 
measured using gas chromatography-tandem 
mass spectrometry and quantified using iso-
tope dilution calibration (Bravo et al. 2002).
We measured six DAP metabolites in 
maternal and child urine: a) three dimethyl 
phosphate (DM) metabolites (dimethylphos-
phate, dimethylthiophosphate, dimethyldi-
thiophosphate), representing breakdown of 
O,O-dimethyl-substituted OP pesticides such 
as malathion, oxydemeton-methyl, and dime-
thoate, and b) three diethyl phosphate (DE) 
metabolites (diethylphosphate, diethylthiophos-
phate, and diethyldithiophosphate) derived 
from O,O-diethyl-substituted OP pesticides 
such as chlorpyrifos and diazinon (Bradman 
et al. 2005). These six metabolites cannot be 
traced back to individual pesticides but, taken 
together, represent the breakdown products of 
approximately 80% of the total OP pesticides 
used in the Salinas Valley. Values below the 
limit of detection (LOD) were assigned a value 
of LOD/√2. Urinary creatinine concentrations 
were determined using a commercially avail-
able diagnostic enzyme method (Vitros CREA 
slides; Ortho Clinical Diagnostics, Raritan, NJ).
Lead, which we considered a potential con-
founder, was measured in cord blood by the 
California State Department of Public Health 
(Sacramento, CA) and in children’s blood at 
age 2 years by the Monterey County Public 
Health Laboratory (Salinas, CA) using graphite 
furnace atomic absorption spectrophotometry. 
Lead levels were abstracted from laboratory and 
clinic medical records by the study staff.
Data analysis. We performed analyses 
using Stata version 10.1 (StataCorp, College 
Station, TX).
DAPs (nanomoles per liter) were summed 
and transformed to the log (base 10) scale; 
coefficients and odds ratios (ORs) thus repre-
sent the change in mean behavioral scores or 
relative odds of an outcome for each 10-fold 
increase in DAP concentration.
Pregnancy DM, DE, and total DAP values 
were created by averaging the two log-trans-
formed pregnancy measures. For 19 women 
with only one DAP measurement in preg-
nancy, the single measure was used. Several 
children were missing DAP measures at 3.5 
years (n = 58) and 5 years (n = 14). Separate 
models were run with maternal DAPs only, 
child DAPs only, and the two together in the 
same model.
We constructed separate linear regres-
sion models for continuous outcomes (e.g., 
NEPSY Visual Attention, CBCL scale scores) 
and logistic regression models for categori-
cal outcomes (e.g., borderline clinical-range 
CBCL scores, markedly atypical K-CPT 
scores). Values of OR > 1.0 or β > 0.0 indicate 
positive associations between DAP levels and 
increased risk of adverse outcome, except for 
the NEPSY visual attention subtest, where a 
β > 0.0 indicates better performance. p-Values 
< 0.05 were considered statistically significant 
for tests of main effects. Model diagnostics 
were performed and found acceptable.
We included the same covariates in all 
models, except that a variable for psychometri-
cian was not included for the CBCL measures. 
Covariates were selected for these analyses if 
they were related to conditions of testing or 
related to neurobehavior in the literature and/
or associated with more than one outcome 
(p < 0.10 or changes to the main effect coef-
ficient by ≥ 10%). We included in the models 
psychometrician (n = 2 at 3.5 years, n = 4 at 
5 years), exact age at assessment, sex, mater-
nal education, depressive symptoms, PPVT 
(continuous), ≥ 15 hr out-of-home child care/
week, and breast feeding duration (months). 
In addition to these covariates, we examined 
the potential confounding effects of a number 
of other variables that did not markedly alter 
the observed associations and were therefore 
not used in models, including maternal age, 
parity, marital status, active/passive smoking 
exposure and regular alcohol use during preg-
nancy, and presence of father in home, mater-
nal work status, and household income at the 
time of assessment. Household income above 
or below poverty was determined by com-
paring total household income with the fed-
eral poverty threshold for a household of that 
size (U.S. Census Bureau 2000). Covariates 
in final models were categorized as noted in 
Table 1, unless otherwise specified above. 
Maternal depression was missing for 5% of 
observations and maternal PPVT for < 1%. 
Values of maternal depression measured when 
the child was 1 year old were available and 
substituted for 13 instances where maternal 
depression when the child was 3.5 years was 
missing. To preserve the size of the analytic 
population, remaining missing covariate val-
ues (six instances for maternal depression and 
three for maternal PPVT) were imputed by 
simple random selection of a value from par-
ticipants with nonmissing values.
We conducted a number of sensitivity 
analyses. We re-ran all models using creati-
nine-adjusted DAP metabolite concentrations. 
In addition, we added to final models some 
factors potentially on the causal pathway (i.e., 
birth weight, gestational duration). We also 
considered whether controlling for lead (log10-
transformed), a known neurotoxicant, altered 
results for DAP concentrations in the subsam-
ples with cord (n = 229) or 2-year (n = 296) 
lead values. Finally, because rates of ADHD 
vary considerably by sex in the general popula-
tion (Pastor and Reuben 2008) and effects of 
other toxicants have been found to vary by 
sex (Delaney-Black et al. 2004), we tested for 
interactions between DAP concentrations and 
child sex, using p < 0.15 for the inter action 
term to determine whether associations of 
DAP concentrations with measures of atten-
tion differed for boys and girls.
Results
Demographic characteristics. Demographic 
characteristics of the study population are pre-
sented in Table 1. Mean (± SD) maternal age 
was 26.5 ± 5.2 years at delivery. Most moth-
ers were married or living as married (82%), 
spoke only Spanish at home (90%), were born 
in Mexico (86%), had not completed high 
school (79%), were nonsmokers (96%), and 
lived in a low-income household (97% within 
200% of the federal threshold for poverty; 
Table 1.  Demographic characterist ics of 
CHAMACOS study population, Salinas Valley, 
California, 2000–2001 (n = 348).
Characteristic n (%)
Mother during pregnancy
Parity
0 114 (32.8)
≥ 1 234 (67.2)
Married or living as married
Yes 285 (81.9)
No 63 (18.1)
Education
≤ Grade 6 149 (42.8)
Grades 7–12 126 (36.2)
≥ High school graduate 73 (21.0)
Country of origin
United States 44 (12.6)
Mexico 298 (85.6)
Other 6 (1.7)
Years in the United States
≤ 5 162 (46.6)
6–10 90 (25.9)
≥ 11 60 (17.2)
Entire life 36 (10.3)
Smoking
Yes 14 (4.0)
No 334 (96.0)
Depressive symptoms (CES-D)
Yes 144 (43.8)
No 185 (56.2)
Poverty status
At or below poverty threshold 205 (62.7)
Above poverty threshold 122 (37.3)
At child follow-up
Child sex
Male 163 (46.8)
Female 185 (53.2)
Child care ≥ 15 hr/week (3.5 years)
Yes 177 (53.3)
No 155 (46.7)
Child care ≥ 15 hr/week (5 years)
Yes 106 (32.8)
No 217 (67.2)
Any preschool by 5 years of age
Yes 228 (69.3)
No 101 (30.7)
Kindergarten by 5 years of age
Yes  96 (29.2)
No 233 (70.8)
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63% within 100%). One third of mothers 
were primiparous, and almost half of mothers 
had symptoms of depression (CES-D ≥ 16). 
About half of the children were in regular out-
of-home child care at 3.5 years of age, and by 
5 years, 69% had attended some preschool. At 
the time of their 5-year assessment, almost one 
third of children had started kindergarten.
Urinary DAP concentrations.  OP 
metabolite concentrations are summarized 
in Table 2. The geometric mean (GM) of 
average prenatal maternal urinary DAP 
concentrations was 109.0 nmol/L. The two 
pregnancy DAP measurements were weakly 
correlated (r = 0.15; p = 0.009). The DAP 
concentrations were lower in children than in 
mothers during pregnancy. Child DAPs were 
uncorrelated with maternal DAPs (Pearson 
r = 0.03; p = 0.60 with 3.5-year measures and 
r = –0.02; p = 0.77 with 5-year measures).
Attention in children 3.5 and 5 years 
of age. When children were 3.5 years old, 
approximately 5% of mothers reported child 
behaviors that were in the borderline clini-
cal range for attention problems and ADHD 
symptoms, with poorer scores on CBCL atten-
tion-related scales among boys than among 
girls [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002056)]. The NEPSY 
visual attention scores averaged 8.8 ± 2.3.
When children were 5 years old, 4% of 
their mothers reported behaviors consistent 
with attention problems and 7% reported 
ADHD symptoms in the borderline clinical 
range; again, scores were higher in boys than 
in girls [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002056)]. On the K-CPT, 
19% of children scored markedly atypical for 
errors of omission, 17% for errors of com-
mission, and 6% for hit reaction time; taken 
together, 8% of children scored ≥ 70% on 
the standardized ADHD Confidence Index 
scale. Boys had higher average scores on the 
ADHD Confidence Index than girls [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002056)]. Psychometricians rated 7% 
of children ≥ 7 on ADHD-related behaviors 
on the Hillside scale, and 8.5% of children 
were classified as having ADHD symptoms at 
5 years according to the composite score.
Continuous CBCL scores were correlated 
across ages (Pearson r = 0.46–0.54; p < 0.01), 
and at each age, all continuous attention 
measures were correlated with one another 
(Pearson r = 0.16–0.85; p < 0.01) except for 
the NEPSY test of visual attention, which was 
not cor related with any outcome (r = –0.09 
to 0.04).
Relation between prenatal DAPs and 
attention. Table 3 (categorical outcomes) and 
Table 4 (continuous outcomes) present the 
relationship of prenatal DAP concentrations 
and measures of child attention, not control-
ling for child DAPs in the models. Adding 
child DAPs as a covariate produced very simi-
lar results (data not shown).
When the children were 3.5 years of age, 
prenatal DAP concentrations were positively 
associated with attention problems [OR = 3.0; 
95% confidence interval (CI), 0.7–11.7; 
p = 0.12] and ADHD (OR = 3.1; 95% CI, 
0.8–11.5; p = 0.09) in the borderline clinical 
range on the CBCL, although estimates were 
not statistically significant.
When the children were 5 years of age, 
prenatal total DAP levels, and DM levels spe-
cifically, were associated with maternal report 
(CBCL) of both ADHD scores and poorer 
attention scores when the scores were exam-
ined as continuous outcomes (Table 4) but 
not as categorical outcomes (Table 3). Total 
DAP concentrations (and total DM and DE 
concentrations separately) were nonsignifi-
cantly associated with the continuous K-CPT 
ADHD Confidence Index scores (Table 4) and 
were significantly associated with this index 
when it was modeled as a dichotomous vari-
able (Table 3). Specifically, for each 10-fold 
increase in DAP concentrations, children had 
five times the odds of scoring > 70% on the 
ADHD Confidence Index (OR = 5.1; 95% CI, 
1.7–15.7). Prenatal total DAP concentrations 
were nonsignificantly associated with the psy-
chometrician Hillside ratings of poor attention 
(OR = 3.0; 95% CI, 0.9–9.8; p = 0.06). Total 
DAP concentrations, and DM concentrations 
Table 2. GM concentrations (nmol/L) of average maternal urinary DAP metabolitesa during pregnancy, 
CHAMACOS Study, Salinas Valley, California [GM (95% CI)].
Marker of exposurea Pregnancy (n = 348) 3.5 Years (n = 290) 5 Years (n = 320)
Total DAPs 109.0 (99.4–119.6) 77.5 (65.4–91.9) 92.6 (78.6–109.0)
Total DEs 17.7 (16.1–19.4) 7.0 (5.8–8.3) 7.2 (6.0–8.7)
Total DMs 76.8 (69.3–85.0) 62.5 (52.2–74.7) 72.4 (61.0–86.0)
aNot adjusted for creatinine; measurements below the LOD were assigned a value of LOD/√2. 
Table 3. Adjusteda logistic models for attention-related outcomes at 3.5 and 5 years of age per 10-fold 
increase in prenatal urinary DAP concentrations [OR (95% CI)].
Model noutcome/n DAPs DEs DMs
3.5 Years
CBCL
Attention problems 17/330 3.0 (0.7–11.7) 2.1 (0.6–7.0) 3.2 (0.9–11.3)*
ADHD 18/329 3.1 (0.8–11.5)* 2.8 (0.9–8.9)* 1.3 (0.4–4.4)
5 Years
CBCL
Attention problems 13/322 0.8 (0.2–3.8) 0.7 (0.2–2.8) 2.0 (0.5–8.5)
ADHD 23/322 1.1 (0.3–3.5) 1.1 (0.4–3.2) 1.3 (0.4–4.0)
K-CPT
Markedly atypical
Percent omissions 59/312 1.5 (0.7–3.3) 1.3 (0.6–2.8) 1.9 (0.9–4.1)
Percent commissions 54/312 1.0 (0.5–2.2) 0.8 (0.4–1.6) 1.2 (0.6–2.7)
Hit reaction time 20/311 1.6 (0.5–5.2) 1.5 (0.5–4.6) 1.1 (0.3–3.6)
ADHD Confidence Index
> 70th percentile 25/297 5.1 (1.7–15.7)# 3.2 (1.2–8.9)** 6.6 (2.2–19.3)#
Hillside Behavioral Rating Scale
Attention ≥ 7 of 12 23/322 3.0 (0.9–9.8)* 2.9 (1.0–8.5)* 2.3 (0.7–7.4)
Composite ADHD indicator
ADHD indicator 27/319 3.5 (1.1–10.7)** 3.0 (1.1–8.2)** 1.7 (0.5–5.5)
aAdjusted for psychometrician, age at assessment, sex, child care, breast-feeding, maternal education, depressive 
symptoms, and PPVT. *p < 0.10. **p < 0.05. #p < 0.01.
Table 4. Adjusteda linear models for attention-related outcomes at 3.5 and 5 years of age per 10-fold 
increase in prenatal urinary DAP concentrations [β (95% CI)].
Model n DAPs DMs DEs
3.5 Years
CBCL
Attention problems 330 0.3 (–0.2 to 0.7) 0.3 (–0.1 to 0.7)* 0.0 (–0.5 to 0.4)
ADHD 329 0.5 (–0.3 to 1.3) 0.6 (–0.1 to 1.3)* –0.2 (–0.9 to 0.6)
NEPSY
Visual attention 319 0.2 (–0.5 to 0.8) 0.1 (–0.5 to 0.6) –0.2 (–0.8 to 0.5)
5 Years
CBCL
Attention problems 322 0.7 (0.2 to 1.2)** 0.6 (0.2 to 1.0)** 0.4 (–0.1 to 0.9)
ADHD 322 1.3 (0.4 to 2.1)** 1.1 (0.3 to 1.9)** 0.7 (–0.2 to 1.5)
K-CPT
ADHD Confidence Index 297 3.4 (–1.8 to 8.7) 2.0 (–2.8 to 6.9) 3.4 (–1.7 to 8.6)
aAdjusted for psychometrician, age at assessment, sex, child care, breast-feeding, maternal education, depressive 
symptoms, and PPVT. *p < 0.10. **p < 0.05.
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specifically, were associated with having ADHD 
signs using the composite indicator (total DAPs 
OR = 3.5; 95% CI, 1.1–10.7), which is based 
on the three assessment methods (i.e., ADHD 
signs based on least two of the three following 
measures: maternal report on the CBCL; child 
performance on the K-CPT; and psychometri-
cian ratings on the Hillside scale) and is thus 
not independent of the individual components.
Using creatinine-adjusted DAP levels 
led to conclusions similar to those presented 
above [Supplemental Material, Tables 2 and 
3 (doi:10.1289/ehp.1002056)]. Some rela-
tionships were stronger, whereas others were 
attenuated. In addition, birth weight, gesta-
tional age, breast-feeding, and lead did not 
confound associations between DAPs and 
attention or ADHD, because these factors did 
not change the main effect estimates by > 10% 
when added to or removed from models.
We also tested whether the associations of 
prenatal DAP concentrations and measures of 
attention were different for boys and girls, as 
shown in Table 5 (categorical outcomes) and 
Table 6 (continuous outcomes). We found 
evidence for effect modification by sex on the 
association of prenatal DAP metabolite concen-
trations and maternal report of attention prob-
lems and ADHD symptoms on the CBCL; at 
3.5 years and 5 years, no associations were seen 
for girls, but among boys, DAP concentrations 
were significantly associated with poorer atten-
tion and ADHD scores (Table 6). We also 
observed stronger associations among boys than 
among girls for several categorical outcomes, 
including CBCL outcomes in the borderline 
clinical range, high K-CPT Confidence Index 
scores, scoring ≥ 7 on the Hillside ADHD 
scale, and the composite measure, but only the 
interaction terms for the Hillside ADHD scale 
and composite ADHD indicator models were 
statistically significant (p < 0.15) (Table 5).
Relation between child DAPs and 
 attention. We did not observe statistically 
significant associations between children’s 
concurrent total DAP concentrations and 
any of the measures of attention, whether we 
adjusted for creatinine or not (Tables 7 and 
8) and with or without (not shown) mater-
nal DAPs in the models. However, we did 
observe that for every 10-fold increase in child 
urinary DE concentration at 5 years, there 
was a doubling in the odds in the ADHD 
composite indicator variable (OR = 2.0; 95% 
CI, 1.1–3.6). We observed no statistically 
significant increase in adverse outcomes with 
child DM concentrations.
Discussion
We found that higher concentrations of OP 
metabolites in the urine of pregnant women 
were associated with increased odds of atten-
tion problems and poorer attention scores in 
their young children. This finding was rela-
tively consistent using different approaches to 
assess attentional difficulties, for example, by 
maternal report, psychometrician observation, 
or neuropsychological testing. These associa-
tions appeared to be somewhat stronger at 
5 years than at 3.5 years and were generally 
stronger in boys than in girls. Children’s con-
current total DAP and DM metabolite levels 
at 3.5 years and 5 years were unrelated to 
attention outcomes, but we observed some 
evidence that child DE concentrations at 
5 years were adversely related to our compos-
ite measure of attention.
Although OP pesticides are designed to tar-
get the nervous systems of pests, few studies 
have investigated a possible role for exposure 
to these chemicals on children’s neurobehavior. 
Our findings suggest that exposure to OP pesti-
cides may affect the attention of young children. 
Although we did not observe similar associa-
tions in this cohort between prenatal DAP con-
centrations and attention on the CBCL among 
2-year-olds (Eskenazi et al. 2007), such behav-
iors may not yet have been evident or consid-
ered atypical at this younger age.
Our current findings are consistent 
with those from a cohort study of African-
American and Dominican-American children 
in New York City, which found prenatal 
blood concentrations of chlorpyrifos to be 
associated with maternal report of ADHD/
attention problems at 3 years of age (Rauh 
et al. 2006) using the CBCL, the same instru-
ment we used at 2, 3.5, and 5 years of age. 
Our study is also consistent with a study of a 
nationally representative sample that reported 
associations between child DAP concentra-
tions (primarily DMs) and ADHD assessed 
via a parental interview (Bouchard et al. 
2010). Children in that study were consider-
ably older (8–15 years of age) than our popu-
lation. Another study of Hispanic children 
(mean age = 7 years) living in an agricultural 
community reported adverse associations of 
Table 5. Adjusteda logistic models for attention-related outcomes at 3.5 and 5 years of age per 10-fold 
increase in prenatal urinary DAP concentrations, stratified by sex.
Model
Boys Girls p-Value for 
interactionnoutcome/n OR (95% CI) noutcome/n OR (95% CI)
3.5 Years
CBCL
Attention problems 12/151 4.1 (0.8–22.2) 5/179 2.1 (0.2–29.9) 0.68
ADHD 12/151 6.4 (1.1–39.0)** 6/176 1.0 (0.1–11.2) 0.21
5 Years
CBCL
Attention problems 10/154 1.0 (0.2–6.0) 3/168 0.6 (0.0–17.3) 0.77
ADHD 14/154 4.9 (0.7–33.0) 9/168 0.3 (0.0–2.2) 0.18
K-CPT
Markedly atypical
Percent omissions 21/148 1.7 (0.4–6.4) 38/164 1.4 (0.5–4.0) 0.90
Percent commissions 24/148 0.9 (0.2–3.2) 30/164 1.2 (0.4–3.3) 0.89
Hit reaction time 7/147 1.2 (0.1–11.5) 13/164 1.7 (0.4–7.4) 0.72
ADHD Confidence Index
> 70th percentile 14/140 10.1 (1.6– 65.3)** 11/157 3.3 (0.6–17.0) 0.41
Hillside Behavioral Rating Scale
Attention ≥ 7 of 12 14/153 7.9 (1.4–46.0)** 9/169 1.0 (0.2–5.9) 0.14
Composite ADHD indicator
ADHD indicator 19/150 11.1 (1.8– 66.5)# 8/169 1.1 (0.2–7.1) 0.13
aAdjusted for psychometrician, age at assessment, sex, maternal education, depressive symptoms, PPVT, child care, 
and breast-feeding. **p < 0.05. #p < 0.01.
Table 6. Adjusteda linear models for continuous attention-related outcomes at 3.5 and 5 years of age per 
10-fold increase in prenatal urinary DAP concentrations, stratified by sex.
Model 
Boys Girls p-Value for 
interactionn β (95% CI) n β (95% CI)
3.5 Years
CBCL
Attention problems 151 0.7 (0.0 to 1.4)** 179 –0.1 (–0.7 to 0.5) 0.05
ADHD 151 1.3 (0.1 to 2.5)** 178 –0.2 (–1.2 to 0.8) 0.06
NEPSY
Visual attention 143 0.2 (–0.8 to 1.1) 176 0.2 (–0.7 to 1.2) 0.99
5 Years
CBCL
Attention problems 154 0.9 (0.2 to 1.7)** 168 0.4 (–0.2 to 1.0) 0.28
ADHD 154 1.9 (0.6 to 3.2)# 168 0.6 (–0.5 to 1.6) 0.13
K-CPT
ADHD Confidence Index 140 6.3 (–0.5 to 13.3)* 157 0.5 (–7.2 to 8.3) 0.39
aAdjusted for psychometrician, age at assessment, sex, maternal education, depressive symptoms, PPVT, child care, 
and breast-feeding.*p < 0.10. **p < 0.05. #p < 0.01.
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child urinary DAPs and attention-related 
performance errors on the Wisconsin Card 
Sorting Test; however the population was 
small (n = 48) (Lizardi et al. 2008). In the 
present study, associations between attention 
measures and prenatal DAPs are stronger 
than those with child DAP concentrations. 
Furthermore, results with child DAPs must be 
viewed with caution, because they reflect con-
current exposures, the temporal relation with 
the outcome is unclear, and exposure may not 
be independent of childhood behavior.
We find some evidence of effect modifica-
tion by sex of the child. The clinical presenta-
tion of attention deficit disorder may vary by 
the child’s sex, with girls reportedly display-
ing more inattentive-type problems and boys 
displaying more hyperactive and impulsive 
behaviors (Biederman et al. 2002; Staller and 
Faraone 2006). Studies of other substances 
have found marked differences in neurotoxic 
susceptibility by sex. For example, one study 
found that 6-year-old boys prenatally exposed 
to cocaine displayed more problem behaviors 
(hyperactivity) than controls but observed 
no such differences among girls (Delaney-
Black et al. 2004). A recent meta-analysis 
reported that differences in brain morphology 
between youth with ADHD and controls var-
ied by child sex (Hutchinson et al. 2008), and 
a functional imaging study found that men 
with ADHD displayed different neural activ-
ity patterns than controls, but women did not 
(Valera et al. 2010).
The mechanisms by which OPs could 
cause attentional problems and/or impulsiv-
ity can be only speculated, as ADHD is a 
complex disorder and the precise causes 
are unknown. However, there is consider-
able evidence that neurotransmitters includ-
ing dopamine, noradrenaline, and serotonin, 
the primary target of ADHD pharmacologic 
treatments, are involved. Less is known about 
the role of the cholinergic system. Although 
OP pesticides at high doses will inhibit acetyl-
cholinesterase, experimental evidence in ani-
mals suggests that even OP doses that cause 
no or little cholinesterase inhibition may 
produce biochemical and behavioral effects 
(Costa 2006), including adverse effects on 
sustained attention and an increase in impul-
sivity in rodents (Middlemore-Risher et al. 
2010). In addition, there is a growing body 
of evidence that OPs may operate through a 
variety of noncholinergic mechanisms, such 
as by disruption of various cellular processes 
such as DNA replication and axonal and 
dendritic growth (Howard et al. 2005) and 
by oxidative stress in the developing brain 
(Slotkin and Seidler 2009).
Our study has many strengths. We were 
able to assess prenatal OP exposure and follow 
the children longitudinally. Our findings are 
generally consistent whether we use creatinine 
or non-creatinine-adjusted DAP metabolite 
concentrations. Although DAP concentra-
tions were not associated with all outcomes, 
we found evidence for an association across 
various assessment methods, including mater-
nal report, child testing, and subjective obser-
vation by evaluators blinded to exposure.
This study has some limitations. Notably, 
the assessment of exposure to OPs is challeng-
ing because of the rapid metabolism of OP 
pesticides (Needham 2005) and the lack of 
a measure of long-term exposure; however, 
because the prenatal measures are an average 
of two measurements, they may better reflect 
ongoing exposure during the pregnancy. Also, 
the prenatal maternal urinary DAP concen-
trations in our study are higher than in a 
nationally representative sample of women 
of childbearing age (109.0 vs. 82.3 nmol/L) 
(Bradman et al. 2005; CDC 2004) and there-
fore may not be generalizable to less-exposed 
populations.
Another limitation is that some of the 
measures we used to assess behavior in these 
Mexican-American children were standardized 
for the general U.S. population. Therefore, 
the percentage of children identified as hav-
ing a problem may not be comparable with 
that expected for the general U.S. population. 
Nevertheless, this limitation should not affect 
the examination of the relative associations of 
DAPs and outcomes within our own homo-
geneous study population.
Future studies should evaluate whether 
associations of OP exposure and attention 
disorders persist in older children and in chil-
dren in different populations. ADHD is often 
not diagnosed until children are of school 
age, and screening instruments may identify 
attention problems more accurately in older 
children than in preschoolers. In addition, 
future investigations should consider whether 
children with certain genetic polymorphisms 
(e.g., paraoxonase 1) may be more likely to 
show attention problems in relation to OP 
exposure. Approximately 8–9% of school-age 
children are estimated to have ADHD (Pastor 
and Reuben 2008); given that attention 
Table 7. Adjusteda logistic regression model for attention-related outcomes at ages 3.5 and 5 years per 
10-fold increase in child urinary DAP concentrations [OR (95% CI)].
Model noutcome/n Total DAPs DMs DEs
3.5 Years
CBCL
Attention problems 17/289 1.6 (0.8–3.5) 1.6 (0.8–3.3) 1.9 (0.9–3.9)
ADHD 17/288 1.4 (0.7–3.1) 1.4 (0.7–3.0) 1.0 (0.5–2.2)
5 Years
CBCL
Attention problems 13/319 1.0 (0.4–2.4) 0.9 (0.4–2.1) 1.8 (0.8–3.9)
ADHD 22/319 0.6 (0.3–1.2) 0.5 (0.3–1.1)* 0.9 (0.5–1.7)
K-CPT
Markedly atypical
Percent omissions 58/309 1.0 (0.6–1.6) 0.9 (0.6–1.5) 1.5 (1.0–2.2)*
Percent commissions 53/309 1.1 (0.7–1.7) 1.1 (0.7–1.8) 0.9 (0.6–1.4)
Hit reaction time 19/308 1.1 (0.5–2.3) 1.0 (0.5–2.0) 1.3 (0.7–2.4)
ADHD Confidence Index
> 70th percentile 24/294 1.3 (0.7–2.5) 1.2 (0.7–2.3) 1.5 (0.8–2.8)
Hillside Behavioral Rating Scale
Attention ≥ 7 of 12 23/319 1.4 (0.7–2.8) 1.1 (0.6–2.1) 1.4 (0.8–2.6)
Composite ADHD indicator
ADHD indicator 25/316 1.0 (0.5–2.0) 0.8 (0.4–1.5) 2.0 (1.1–3.6)**
aAdjusted for maternal total DAPs, psychometrician, age at assessment, sex, maternal education, depressive symptoms, 
PPVT, child care, and breast-feeding, as well as maternal urinary DAPs. *p < 0.10. **p < 0.05.
Table 8. Adjusteda linear regression models for attention-related outcomes at ages 3.5 and 5 years per 
10-fold increase in child urinary DAP concentrations [β (95% CI)].
Model n Total DAPs DMs DEs 
3.5 Years
CBCL
Attention problems 289 0.1 (–0.2 to 0.4) 0.1 (–0.2 to 0.3) 0.2 (0.0 to 0.5)*
ADHD 288 0.1 (–0.3 to 0.6) 0.1 (–0.3 to 0.6) 0.2 (–0.3 to 0.7)
NEPSY
Visual attention 277 –0.1 (–0.5 to 0.3) –0.1 (–0.5 to 0.3) –0.1 (–0.5 to 0.3)
5 Years
CBCL
Attention problems 319 0.0 (–0.3 to 0.2) –0.1 (–0.3 to 0.2) 0.0 (–0.2 to 0.3)
ADHD 319 0.0 (–0.5 to 0.5) 0.0 (–0.5 to 0.4) 0.1 (–0.3 to 0.6)
K-CPT
ADHD Confidence Index 294 –0.7 (–3.8 to 2.3) –1.0 (–3.9 to 1.9) 2.2 (–0.5 to 5.0)
aAdjusted for maternal total DAPs, psychometrician, age at assessment, sex, maternal education, depressive symptoms, 
PPVT, child care, and breast-feeding, as well as maternal urinary DAPs. *p < 0.10.
Marks et al.
1774 volume 118 | number 12 | December 2010 • Environmental Health Perspectives
problems of children interfere with learning 
and social development, finding potential 
causes that can be remediated are of great 
public health importance.
Conclusion
In utero DAP and, to a lesser extent, child 
DAP concentrations were associated adversely 
with attention in young children as assessed 
by maternal report, psychometrician observa-
tion, and/or direct assessment. These associa-
tions were somewhat stronger at 5 years than 
at 3.5 years and in boys than in girls.
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